Cargando…
Intratumoral Distribution and pH-Dependent Drug Release of High Molecular Weight HPMA Copolymer Drug Conjugates Strongly Depend on Specific Tumor Substructure and Microenvironment
Stimulus-sensitive polymer drug conjugates based on high molecular weight N-(2-hydroxypropyl) methacrylamide (HPMA) copolymers carrying doxorubicin via a pH-dependent cleavable bond (pHPMA-Dox) were previously shown to be able to overcome multi-drug resistance. Nevertheless, a tumor type dependent d...
Autores principales: | Noack, Anne-Kathrin, Lucas, Henrike, Chytil, Petr, Etrych, Tomáš, Mäder, Karsten, Mueller, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7504030/ https://www.ncbi.nlm.nih.gov/pubmed/32825790 http://dx.doi.org/10.3390/ijms21176029 |
Ejemplares similares
-
HPMA Copolymer-Based Nanomedicines in Controlled Drug Delivery
por: Chytil, Petr, et al.
Publicado: (2021) -
Biocompatible glyconanomaterials based on HPMA-copolymer for specific targeting of galectin-3
por: Bojarová, P., et al.
Publicado: (2018) -
HPMA-Based Copolymers Carrying STAT3 Inhibitor Cucurbitacin-D as Stimulus-Sensitive Nanomedicines for Oncotherapy
por: Tavares, Marina R., et al.
Publicado: (2021) -
HPMA-Based Polymer Conjugates for Repurposed Drug Mebendazole and Other Imidazole-Based Therapeutics
por: Studenovský, Martin, et al.
Publicado: (2021) -
HPMA Copolymer Mebendazole Conjugate Allows Systemic Administration and Possesses Antitumour Activity In Vivo
por: Studenovský, Martin, et al.
Publicado: (2022)